quadgram

This is a table of type quadgram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

quadgram	frequency
hematopoietic stem cell transplantation	504
of conflict of interest	479
disclosure of conflict of	479
allogeneic hematopoietic stem cell	258
at the time of	245
the aim of this	188
of this study was	180
this study was to	173
aim of this study	170
allogeneic stem cell transplantation	169
graft versus host disease	165
in the absence of	133
abstract case report text	132
in the presence of	129
in the setting of	123
for the treatment of	112
a total of patients	107
autologous stem cell transplantation	106
median age was years	101
with a median follow	101
at a median of	99
in the treatment of	96
is one of the	90
cd and cd t	89
this is the first	88
a median age of	87
was found to be	85
an important role in	84
hematopoietic stem cell transplant	83
peripheral blood stem cells	81
with a median age	81
p disclosure of conflict	80
in a patient with	79
there was no significant	79
as well as the	79
a median of days	79
has been shown to	78
at the age of	78
in the context of	77
was found to have	77
of this study is	76
is the most common	76
with a history of	76
this study is to	73
after allogeneic hematopoietic stem	72
on the other hand	72
in the pathogenesis of	71
study was to evaluate	71
at the end of	70
were included in the	67
the median age was	66
report a case of	65
the majority of patients	64
peripheral blood stem cell	64
acute and chronic gvhd	64
and cd t cells	64
play a role in	62
we report a case	62
as a result of	62
to be associated with	62
nothing to declare background	62
patients were treated with	60
has been associated with	60
median age of years	60
allogeneic hematopoietic cell transplantation	59
stem cell transplantation in	59
for the first time	59
for the development of	58
median follow up of	58
the median time to	57
was to evaluate the	57
one of the most	56
in the development of	56
a retrospective chart review	55
at years of age	55
was no significant difference	54
peripheral blood mononuclear cells	54
of cd t cells	54
play an important role	53
the purpose of this	53
of the immune system	53
the cumulative incidence of	53
nothing to declare p	52
the case of a	52
there was no difference	51
the aim of the	51
is associated with a	51
studies are needed to	51
it is important to	50
was significantly higher in	49
we performed a retrospective	49
in the united states	49
in pediatric patients with	49
after allogeneic stem cell	49
an increased risk of	48
in the present study	48
at months of age	48
a median follow up	48
in this study we	48
should be considered in	48
with sickle cell disease	47
the median age of	47
specific cd t cells	47
a median time of	47
been shown to be	46
have been shown to	46
no significant difference in	45
the median age at	45
a case of a	45
at a dose of	45
case report text introduction	45
were found to be	44
neutrophil and platelet engraftment	44
after hematopoietic stem cell	44
the end of the	44
haematopoietic stem cell transplantation	44
of cd and cd	44
was associated with a	43
little is known about	43
the median number of	43
have been associated with	42
aim of the study	42
our data suggest that	42
of morbidity and mortality	42
safety and efficacy of	42
after a median follow	42
in vitro and in	41
included in the study	41
purpose of this study	41
at the same time	41
in the majority of	41
in the regulation of	41
may be associated with	41
our aim was to	40
morbidity and mortality in	40
cumulative incidence of relapse	40
of the patients with	40
in the case of	40
we present a case	40
t cells in the	40
autologous hematopoietic stem cell	39
number of cd cells	39
our results suggest that	39
acute graft versus host	39
vitro and in vivo	39
are shown in table	39
there were no significant	39
between the two groups	38
median time to neutrophil	38
as well as in	38
of allogeneic hematopoietic stem	38
in the control group	38
of the study was	38
cause of morbidity and	37
of our study was	37
to the development of	37
were included in this	37
in patients who received	37
we were able to	37
the central nervous system	37
stem cell transplantation for	37
the aim of our	37
retrospective chart review of	37
stem cell source was	37
aim of our study	36
a member of the	36
the objective of this	36
with the use of	36
on the basis of	36
the median duration of	36
reported in the literature	35
we conducted a retrospective	35
cohort of patients with	35
of acute and chronic	35
the age of years	35
national institutes of health	35
a risk factor for	35
important role in the	35
the presence of a	35
patients with multiple myeloma	34
on the surface of	34
was no difference in	34
present a case of	34
no significant differences in	34
case report text background	33
in the number of	33
and the presence of	33
total of patients were	33
objective of this study	33
the number of cd	33
the time of the	33
during the study period	33
with acute myeloid leukemia	33
in the peripheral blood	33
was observed in patients	33
of the patients had	33
of a patient with	33
acute or chronic gvhd	33
with a median of	33
in the differential diagnosis	33
the main cause of	32
the study was to	32
was the most common	32
of the patients who	32
cd t cells were	32
presence or absence of	32
there were no differences	32
were found to have	32
enrolled in the study	32
in a cohort of	32
study was to investigate	31
stem cell transplantation is	31
were no significant differences	31
patients with hematological malignancies	31
these results suggest that	31
found to have a	31
none of the patients	31
those who did not	31
patients with sickle cell	31
were enrolled in the	31
plays an important role	30
caused by mutations in	30
t and b cells	30
in of the patients	30
of the immune response	30
the safety and efficacy	30
as part of the	30
the differential diagnosis of	30
our study was to	30
study was to determine	29
efficacy and safety of	29
associated with an increased	29
study is to evaluate	29
present the case of	29
have been reported in	29
patients who did not	29
was to determine the	28
in the group of	28
solid organ transplant recipients	28
these data suggest that	28
a significant increase in	28
blood stem cell transplantation	28
with the development of	28
patient was started on	28
compared to healthy controls	28
of the present study	28
he was diagnosed with	28
a cohort of patients	28
the presence of the	28
vg vd t cells	28
in the bone marrow	28
with a diagnosis of	28
the presence or absence	28
chronic graft versus host	28
age at transplant was	28
most of the patients	27
gvhd prophylaxis consisted of	27
was to investigate the	27
haploidentical stem cell transplantation	27
included in this study	27
the first year of	27
a major cause of	27
were more likely to	27
is the only curative	27
in addition to the	27
cd t cells and	27
a role in the	27
she was started on	27
of the patients were	27
the role of the	27
was significantly associated with	27
was not statistically significant	26
with no evidence of	26
the quality of life	26
has been described in	26
of the patients was	26
a matched unrelated donor	26
is known about the	26
the expression of the	26
best of our knowledge	26
he was treated with	26
report the case of	26
we present the case	26
risk of multiple sclerosis	26
the expression of cd	26
in the course of	26
a retrospective analysis of	26
dose of mg kg	26
significantly higher in the	26
the development of a	26
patients with high risk	26
the best of our	26
was not associated with	26
for the presence of	26
large b cell lymphoma	26
of allergy and infectious	25
institute of allergy and	25
allergy and infectious diseases	25
it is possible that	25
may contribute to the	25
after a median of	25
for the diagnosis of	25
we report the case	25
investigate the role of	25
follow up of months	25
between january and december	25
age of the patients	25
as well as a	25
national institute of allergy	25
review of the literature	25
he was found to	25
in patients with multiple	25
median age at diagnosis	25
source of stem cells	25
to the best of	25
diffuse large b cell	25
at a median follow	25
has been reported in	24
studies have shown that	24
conditioning regimen consisted of	24
in the first days	24
incidence of acute gvhd	24
t and b cell	24
a dose of mg	24
with the presence of	24
statistical analysis was performed	24
cells as well as	24
in a variety of	24
described in the literature	24
in the general population	24
evaluate the impact of	24
diagnosis and management of	24
can be used to	24
of hematopoietic stem cell	24
analysis was performed using	23
to better understand the	23
during the first year	23
total of patients with	23
it has been shown	23
after stem cell transplantation	23
of patients who received	23
blood and marrow transplantation	23
be considered in the	23
are summarized in table	23
no statistically significant difference	23
in the first year	23
median age at transplant	23
cd t cells in	23
the stem cell source	23
study was to analyze	23
allogeneic haematopoietic stem cell	23
the incidence of acute	23
for the detection of	23
was significantly lower in	23
was shown to be	23
option for patients with	23
the first case of	23
in patients with high	23
a critical role in	23
the conditioning regimen was	23
was to assess the	23
time from diagnosis to	23
were significantly higher in	23
and after the outbreak	22
on the use of	22
in the diagnosis of	22
patient was diagnosed with	22
b and nk cells	22
source was peripheral blood	22
in patients treated with	22
with an increased risk	22
a crucial role in	22
severe acute respiratory syndrome	22
are involved in the	22
at different time points	22
the results of the	22
in this retrospective study	22
median time of days	22
he was started on	22
cause of death in	22
a key role in	22
median age of the	22
the efficacy and safety	22
cells were positive for	22
she was diagnosed with	22
is thought to be	22
and the number of	22
a higher risk of	22
retrospective chart review was	22
is associated with increased	22
in the management of	22
to evaluate the impact	22
age of patients was	22
the present study was	22
results suggest that the	22
was significantly higher than	22
patients were diagnosed with	22
no conflict of interest	22
from january to december	22
is to evaluate the	22
of patients with a	22
median age of patients	22
adolescents and young adults	22
in the pediatric population	22
the course of the	21
and the patient was	21
be used as a	21
or in combination with	21
a retrospective study of	21
describe a case of	21
with a median time	21
haploidentical hematopoietic stem cell	21
most common cause of	21
a year old male	21
our results show that	21
patients with acute myeloid	21
of cd cells in	21
the only curative treatment	21
we have shown that	21
we retrospectively analyzed the	21
in the current study	21
acute gvhd grade ii	21
of patients who underwent	21
and the development of	21
the time of diagnosis	21
the patient was started	21
to investigate the role	21
had at least one	21
test was used to	21
with the addition of	21
was found in the	21
further studies are needed	21
be considered as a	21
our results indicate that	21
incidence of chronic gvhd	21
had a history of	21
may play a role	21
allogeneic stem cell transplant	21
a high risk of	21
of the patients received	21
of multiple sclerosis in	21
the first report of	21
study was to assess	21
in children with scd	21
at the start of	21
patients were included in	21
in any of the	21
was defined as the	21
significant difference in the	21
on the presence of	20
we did not find	20
the most common cause	20
porcine reproductive and respiratory	20
of herpes simplex virus	20
a better understanding of	20
with increased risk of	20
role in the pathogenesis	20
to the presence of	20
in the presence or	20
with median age of	20
was detected in patients	20
course was complicated by	20
are the most common	20
has been shown that	20
was observed in the	20
patient was treated with	20
we found that the	20
bone marrow biopsy was	20
associated with increased risk	20
has been reported to	20
causes of death were	20
there was no statistically	20
a high rate of	20
and is associated with	20
patients with acute leukemia	20
is the first case	20
the mean age was	20
acute respiratory distress syndrome	20
in patients with a	20
more likely to have	20
there was a significant	20
on the day of	20
expression of cd and	20
and cd t cell	20
reproductive and respiratory syndrome	20
to be involved in	20
a retrospective review of	20
we report our experience	20
is a primary immunodeficiency	20
in the era of	20
of the most common	20
patients with and without	19
did not show any	19
the vast majority of	19
an increase in the	19
aim of the present	19
as a consequence of	19
age at diagnosis was	19
high morbidity and mortality	19
at the onset of	19
of the study is	19
this study aimed to	19
survival in patients with	19
higher in patients with	19
for hematopoietic stem cell	19
with the exception of	19
were significantly lower in	19
were no differences in	19
switched memory b cells	19
were in complete remission	19
the majority of cases	19
is the first report	19
the median time of	19
is involved in the	19
the outcome of patients	19
associated with the development	19
in the expression of	19
at high risk for	19
were not significantly different	19
case of a year	19
is based on the	19
in patients with aml	19
of the conditioning regimen	19
a mean age of	19
high index of suspicion	19
the innate immune system	19
by flow cytometry and	19
patients died due to	19
estimates of genetic correlations	19
with common variable immunodeficiency	19
patients with a median	19
alone or in combination	18
treatment of patients with	18
of patients who were	18
allogenic hematopoietic stem cell	18
the median time from	18
by the presence of	18
and autologous stem cell	18
was no statistically significant	18
in patients with scd	18
the use of a	18
is a rare disease	18
there was a trend	18
has the potential to	18
with acute lymphoblastic leukemia	18
the lower respiratory tract	18
patients with primary immunodeficiency	18
by mutations in the	18
a single center experience	18
the majority of the	18
were significantly associated with	18
of the innate immune	18
specific cd and cd	18
in patients with severe	18
and was found to	18
of patients treated with	18
she was treated with	18
of the gastrointestinal tract	18
outcome of patients with	18
of minimal residual disease	18
compared to patients with	18
prevention and treatment of	18
treatment for patients with	18
patients were divided into	18
not significantly different between	18
can be used as	18
of allogeneic stem cell	18
when compared to the	18
the standard of care	18
was peripheral blood in	18
to neutrophil and platelet	18
was used to compare	18
a heterogeneous group of	18
in patients with acute	18
associated with a higher	18
year cumulative incidence of	18
in this patient population	18
in patients undergoing allogeneic	18
is the most important	18
divided into two groups	18
it is known that	18
at a median time	18
over the course of	18
this is a retrospective	18
patients who underwent allo	17
is associated with the	17
at the university of	17
it has been suggested	17
are at increased risk	17
involved in the regulation	17
determined by flow cytometry	17
a large cohort of	17
and platelet engraftment was	17
of t and b	17
patients with multiple sclerosis	17
no significant difference between	17
the rest of the	17
followed by autologous stem	17
is an autosomal recessive	17
consecutive patients who underwent	17
prior to and after	17
in a subset of	17
months of age with	17
for the management of	17
have been described in	17
has not been reported	17
a wide range of	17
in solid organ transplant	17
a central role in	17
quality of life of	17
a group of patients	17
the mean number of	17
of the patients in	17
was used as a	17
pediatric intensive care unit	17
was approved by the	17
first year of life	17
increase the risk of	17
the use of the	17
were associated with a	17
was found in of	17
be involved in the	17
had no effect on	17
has not been previously	17
the leading cause of	17
group of patients with	17
these results demonstrate that	17
on the outcome of	17
a significant reduction of	17
patients with r r	17
a significant decrease in	17
in the last years	17
cd t cells from	17
the risk of developing	17
have been reported to	17
the only curative option	17
the time of transplantation	17
the overall response rate	17
analyzed by flow cytometry	17
reduced intensity conditioning regimen	17
study was to compare	17
included in the analysis	17
standard of care for	17
after allogeneic hematopoietic cell	17
for patients with high	17
patients are alive and	17
the immune system and	17
both cd and cd	17
in more than of	16
by autologous stem cell	16
and progression free survival	16
hsct in our center	16
were the most common	16
inborn errors of immunity	16
source was bone marrow	16
in a child with	16
our understanding of the	16
of regulatory t cells	16
at high risk of	16
in cd t cells	16
transplantation in patients with	16
the first year after	16
is known to be	16
major cause of morbidity	16
is a paucity of	16
is a frequent complication	16
we report the first	16
as a cause of	16
and the use of	16
stem cell transplantation from	16
the total number of	16
years of age with	16
compared to those with	16
we have developed a	16
reduce the risk of	16
was not significantly different	16
as a marker of	16
the impact of the	16
there is a paucity	16
cd t cell responses	16
a reduced intensity conditioning	16
be considered in patients	16
in order to determine	16
a high level of	16
of gd t cells	16
did not receive any	16
the average number of	16
as well as for	16
in patients who had	16
are associated with a	16
this case highlights the	16
area under the curve	16
a higher incidence of	16
these findings suggest that	16
main cause of death	16
univariate and multivariate analysis	16
b and t cells	16
samples from patients with	16
time to neutrophil engraftment	16
in a series of	16
the national institutes of	16
quality of life and	16
age at hsct was	16
was referred to our	16
median time to platelet	16
a subset of patients	16
at the moment of	16
half of the patients	16
the activation of the	16
but there was no	16
in order to identify	16
mhc class i molecules	16
autologous stem cell transplant	16
conditioning regimen was myeloablative	16
a matched related donor	16
the goal of this	16
our data indicate that	16
the reaction norm model	16
compared to patients without	16
the difference was not	16
in group a and	16
and are associated with	16
all patients were treated	16
a period of years	16
t cell receptor excision	16
we have previously shown	16
highlights the importance of	16
and the risk of	16
as compared to the	16
to be effective in	16
the group of patients	16
dose chemotherapy followed by	15
to play a role	15
of this retrospective study	15
in contrast to the	15
at increased risk of	15
the time of transplant	15
should be considered as	15
of clinical immunology and	15
the analysis of the	15
of patients had a	15
the immune response to	15
of the urinary bladder	15
a patient with a	15
present study was to	15
role in the development	15
as stem cell source	15
and the control group	15
are at risk for	15
and quality of life	15
the age of months	15
compound heterozygous mutations in	15
plays a role in	15
after autologous stem cell	15
year old male with	15
significant differences between the	15
the number of patients	15
severe combined immune deficiency	15
who were treated with	15
this work was supported	15
did not differ between	15
innate and adaptive immune	15
net state of immunosuppression	15
of acute gvhd grade	15
blood samples were collected	15
cell receptor excision circles	15
b and t cell	15
was used in patients	15
may be involved in	15
assessed by flow cytometry	15
it was shown that	15
over a period of	15
is an extremely rare	15
increased risk of ms	15
laboratory of clinical immunology	15
following hematopoietic stem cell	15
compared to that of	15
incidence and severity of	15
dose of mg m	15
variants of uncertain significance	15
of hematopoietic stem cells	15
of pediatric patients with	15
all patients received a	15
in the diagnosis and	15
observed in patients with	15
of cd t cell	15
is a very rare	15
a major role in	15
was also found to	15
was observed in of	15
for acute myeloid leukemia	15
one of the main	15
is characterized by the	15
in the multivariate analysis	15
median follow up was	15
old female presented with	15
cd cells in the	15
may be due to	15
been reported in the	15
admitted to the hospital	15
no conflicts of interest	15
the patient was treated	15
a high index of	15
to the use of	15
proportion of patients with	15
was found in patients	15
cells and nk cells	15
at the university hospital	15
outcomes in patients with	15
in children and adolescents	15
no significant differences were	15
significantly higher in patients	15
the mean age of	15
children and adolescents with	15
old female with a	15
has been suggested that	15
was to analyze the	15
no statistically significant differences	15
to evaluate the efficacy	15
white blood cell count	15
considered in the differential	15
aimed to evaluate the	15
are needed to confirm	15
have been identified in	14
the patient had a	14
associated with a high	14
a matched sibling donor	14
cell transplantation in patients	14
that the use of	14
was to compare the	14
the results of this	14
studies are required to	14
to the diagnosis of	14
she was referred to	14
we describe a case	14
due to lack of	14
occurred at a median	14
a pivotal role in	14
in of the cases	14
median age at transplantation	14
cd and cd cells	14
the tumor cells were	14
a large number of	14
patients with relapsed refractory	14
on the cell surface	14
was the most frequent	14
and the expression of	14
been reported to be	14
have previously shown that	14
in patients with cgd	14
in the process of	14
at the site of	14
at increased risk for	14
should be considered for	14
age at time of	14
of these patients were	14
to declare p abstract	14
therapy for patients with	14
a positive correlation between	14
patients who underwent allogeneic	14
may play an important	14
time to neutrophil and	14
was diagnosed in patients	14
plays a critical role	14
patients who underwent hsct	14
the patient is a	14
from the reaction norm	14
morbidity and mortality after	14
that the expression of	14
was noted to have	14
median cd cell dose	14
our findings suggest that	14
is to investigate the	14
the study is to	14
known to be associated	14
in the control of	14
complication of allogeneic hematopoietic	14
upper respiratory tract infections	14
is a member of	14
more likely to be	14
clinical immunology and microbiology	14
there is no consensus	14
the incidence of chronic	14
in ebv assay system	14
neutrophil engraftment was days	14
we retrospectively reviewed the	14
no difference in the	14
ranged from to years	14
is a rare autosomal	14
induction of the productive	14
the median time for	14
patients were transplanted in	14
here we show that	14
activity in ebv assay	14
and respiratory syndrome virus	14
our objective was to	14
was performed using the	14
in the first months	14
with a mean age	14
cell source was peripheral	14
our data show that	14
the median follow up	14
is the most frequent	14
and review of the	14
at the last follow	14
significant morbidity and mortality	14
a high incidence of	14
the intensive care unit	14
here we report a	14
human immunodeficiency virus type	14
time to platelet engraftment	14
patients who received a	14
and was associated with	14
it was found that	14
hsct in patients with	14
to be safe and	14
cd cell dose was	14
engraftment was achieved in	14
to be related to	14
of the t cell	14
a significant reduction in	14
between the ages of	14
during the course of	14
than years of age	14
a pediatric patient with	14
by the use of	14
the diagnosis and management	14
of chronic gvhd was	14
a rare case of	14
median age at hsct	14
age at transplantation was	14
in allogeneic stem cell	14
a total of children	14
in the field of	14
work was supported by	14
with a variety of	14
the time of hsct	14
history was significant for	14
better understanding of the	14
is a safe and	14
cells in response to	14
sensitivity and specificity of	14
of acute or chronic	14
it has been reported	14
be related to the	14
it is difficult to	14
the incidence of cmv	14
on the type of	13
from an unrelated donor	13
patients with newly diagnosed	13
specific cytotoxic t lymphocytes	13
a case series of	13
were divided into two	13
is a major cause	13
in the two groups	13
a rare autosomal recessive	13
to neutrophil engraftment was	13
revealed the presence of	13
alive and disease free	13
patients with hematologic malignancies	13
it is associated with	13
in accordance with the	13
was seen in of	13
the first days of	13
not reach statistical significance	13
in the evaluation of	13
did not reach statistical	13
fever of unknown origin	13
cd t cells with	13
were divided into groups	13
a history of recurrent	13
was successfully treated with	13
and years of age	13
tacrolimus and mycophenolate mofetil	13
a safe and effective	13
in our center from	13
a review of the	13
median of days after	13
received peripheral blood stem	13
in patients with pid	13
prior to the outbreak	13
was performed in patients	13
may be related to	13
history of recurrent infections	13
to evaluate the safety	13
increases the risk of	13
of t cells in	13
a significant proportion of	13
with chronic granulomatous disease	13
there was no statistical	13
to and after the	13
in line with the	13
the net state of	13
was admitted to the	13
incidence of grade ii	13
of t cell activation	13
medical records of patients	13
the entire cohort was	13
is the first study	13
in out of patients	13
decision was made to	13
to determine the incidence	13
plays a crucial role	13
male to female ratio	13
patients were in complete	13
course of the disease	13
confirming the diagnosis of	13
has been observed in	13
barr virus infection in	13
been implicated in the	13
hematopoetic stem cell transplantation	13
were excluded from the	13
plays a central role	13
for blood and marrow	13
characteristics of the patients	13
in a large cohort	13
majority of the patients	13
we aimed to determine	13
fluorescence in situ hybridization	13
the use of this	13
a statistically significant difference	13
patients with relapsed or	13
the protective effect of	13
is likely to be	13
a broad spectrum of	13
the first year post	13
infections in patients with	13
t and nk cells	13
were more frequent in	13
is characterized by a	13
group and in the	13
these data indicate that	13
by flow cytometry using	13
involved in the pathogenesis	13
the patients who were	13
children and young adults	13
for a median of	13
here we present a	13
mg kg on day	13
on the incidence of	13
therapy in patients with	13
all of the patients	13
she was found to	13
at last follow up	13
to years of age	13
chart review was performed	13
the relationship between the	13
of our study is	13
in the activation of	13
evaluate the safety and	13
performed a retrospective chart	13
been described in the	13
all patients had received	13
in renal transplant recipients	13
are alive and disease	13
of cd cd cd	13
a retrospective cohort study	13
goal of this study	13
was seen in patients	13
children with sickle cell	13
a reduction in the	13
and young adults with	13
the clinical course of	13
was admitted to our	13
age at the time	13
the first days after	13
and total body irradiation	13
on the th day	13
of graft versus host	12
and disease free survival	12
prospective studies are needed	12
significant difference between the	12
the conditioning regimen consisted	12
significantly lower in the	12
the proportion of patients	12
measured by flow cytometry	12
multiple sclerosis multiple sclerosis	12
herpes simplex virus type	12
performed a retrospective analysis	12
is a potentially curative	12
significantly higher than the	12
is a common complication	12
is a marker of	12
is caused by mutations	12
was referred to the	12
of these patients had	12
with respect to the	12
the characteristics of the	12
the incidence and severity	12
patients who had received	12
were observed in patients	12
we hypothesized that the	12
patients received myeloablative conditioning	12
in children and adults	12
conducted a retrospective study	12
patients who had undergone	12
lymphocytic interstitial lung disease	12
were used for the	12
was higher in the	12
in hematopoietic stem cell	12
of patients in the	12
allogeneic bone marrow transplantation	12
we show that the	12
from the same donor	12
confirmed the diagnosis of	12
cell acute lymphoblastic leukemia	12
used in the treatment	12
as a source of	12
has been implicated in	12
case of a patient	12
were significantly higher than	12
correlation was found between	12
a median number of	12
can be associated with	12
median time of months	12
small number of patients	12
patients who were diagnosed	12
the incidence of grade	12
our study is to	12
was observed in all	12
a treatment option for	12
overall survival in patients	12
and graft versus host	12
are more likely to	12
old male with a	12
very good partial response	12
is associated with an	12
and one patient had	12
autologous peripheral blood stem	12
barr virus nuclear antigen	12
is a severe complication	12
are at high risk	12
the nature of the	12
we describe a patient	12
data suggest that the	12
this was a retrospective	12
the mean age at	12
by cd t cells	12
we report on a	12
a rare form of	12
to describe a case	12
a single dose of	12
the time of analysis	12
of human immunodeficiency virus	12
outcomes of patients with	12
of hla class i	12
more common in the	12
a result of the	12
our data suggests that	12
play a key role	12
of the use of	12
only curative option for	12
even in the absence	12
the duration of the	12
median duration of follow	12
and bone marrow transplantation	12
of the central nervous	12
in our center between	12
be included in the	12
method was used to	12
of the pi k	12
in a mouse model	12
were not statistically significant	12
and increased risk of	12
the major cause of	12
in the immune system	12
with severe hemophilia a	12
with the diagnosis of	12
is not associated with	12
were enrolled in this	12
the patient was diagnosed	12
the expression level of	12
informed consent was obtained	12
our data demonstrate that	12
in adult patients with	12
gvhd was observed in	12
the prevalence of ebv	12
presented at months of	12
during the first days	12
of the disease and	12
and an increase in	12
patients undergoing allogeneic hematopoietic	12
the most frequent cause	12
differences between the two	12
the quality of the	12
due to disease progression	12
a median of months	12
for a total of	12
whole exome sequencing was	12
median number of cd	12
of patients were included	12
this group of patients	12
of sickle cell disease	12
in first complete remission	12
mg kg per day	12
a leading cause of	12
patients were conditioned with	12
research is needed to	12
management of patients with	12
in our cohort of	12
in a group of	12
incidence of acute and	12
at transplant was years	12
has been used to	12
a year old female	12
up to of patients	12
cumulative incidence of acute	12
median time from diagnosis	12
significant difference was found	12
study was to identify	12
in the lower respiratory	12
the patients who had	12
baylor college of medicine	12
one or more of	12
risk factors associated with	12
and were included in	12
stem cell transplantation background	12
due to the lack	12
admitted to our hospital	12
the patients who received	12
cells were isolated from	12
of infused cd cells	12
is a risk factor	12
the first day of	12
seen in patients with	12
stem cell transplantation and	12
have been implicated in	12
in the production of	12
no correlation was found	12
between january and june	12
to the lack of	12
this study aims to	12
undergoing allogeneic hematopoietic stem	11
was performed in all	11
a mutation in the	11
he continued to have	11
the gold standard for	11
from the time of	11
in an attempt to	11
significantly different between the	11
more than of the	11
in the incidence of	11
to be the most	11
can be divided into	11
cd and cd cd	11
neutrophil and platelet recovery	11
be associated with an	11
was higher in patients	11
influenza a h n	11
is to determine the	11
end of the first	11
and mortality after allogeneic	11
all of them were	11
hematopoietic stem cells transplantation	11
in all patients with	11
we retrospectively analyzed patients	11
on the expression of	11
with recurrent sinopulmonary infections	11
shown to be associated	11
median time of neutrophil	11
with autologous stem cell	11
patients with mds and	11
years of age and	11
our study suggests that	11
were performed in patients	11
the correlation between the	11
is required for the	11
was well tolerated and	11
in the frequency of	11
patients were found to	11
and is characterized by	11
the median dose of	11
end stage renal disease	11
be associated with a	11
it should be noted	11
should be noted that	11
as shown in figure	11
were obtained from the	11
we present a patient	11
who were diagnosed with	11
with hematopoietic stem cell	11
for patients with relapsed	11
were measured by elisa	11
a mouse model of	11
autologous hematopoietic cell transplantation	11
a myeloablative conditioning regimen	11
despite the fact that	11
status at the time	11
of neutrophil and platelet	11
in children with ckd	11
bacterial and viral infections	11
out of the patients	11
one patient had a	11
for patients with refractory	11
that there is a	11
used to determine the	11
clinical and laboratory data	11
of a variety of	11
a wide spectrum of	11
was defined as a	11
study is to determine	11
mg m on day	11
seems to be a	11
in patients with non	11
with a combination of	11
the median time between	11
was supported by the	11
of cd cells infused	11
variant of unknown significance	11
patients who received an	11
diagnosis and treatment of	11
in the plerixafor group	11
been shown to have	11
a total of cases	11
an effective treatment for	11
the risk of gvhd	11
one of the major	11
is yet to be	11
in the model group	11
chemotherapy followed by autologous	11
the treatment of choice	11
with high levels of	11
we did not observe	11
for their ability to	11
in allogeneic hematopoietic stem	11
pathogenic or likely pathogenic	11
the regulation of the	11
in the induction of	11
at the cell surface	11
umbilical cord blood transplantation	11
has been reported that	11
a family history of	11
following allogeneic hematopoietic stem	11
the present study we	11
university of medical sciences	11
or more of the	11
further studies are warranted	11
in a number of	11
signs and symptoms of	11
and there was no	11
a significant increase of	11
who did not receive	11
in the use of	11
and event free survival	11
the evaluation of the	11
more than half of	11
not significantly associated with	11
the prevention and treatment	11
on the role of	11
in this cohort of	11
p abstract already published	11
did not respond to	11
to determine the prevalence	11
the absence of the	11
from day to day	11
of the bone marrow	11
of a year old	11
as a risk factor	11
which is associated with	11
related or unrelated donor	11
with full donor chimerism	11
year overall survival was	11
not been previously reported	11
chart review was conducted	11
who did not develop	11
a significant cause of	11
the molecular basis of	11
we found a significant	11
on cd t cells	11
our aim is to	11
chart review of patients	11
in order to reduce	11
statistically significant difference was	11
increased morbidity and mortality	11
in an effort to	11
the results showed that	11
it is unclear whether	11
our results demonstrate that	11
it is necessary to	11
carcinoma of the breast	11
at the beginning of	11
these data demonstrate that	11
with severe combined immunodeficiency	11
majority of patients were	11
was initially treated with	11
was associated with an	11
cell transplantation is the	11
similar in both groups	11
of allogeneic hematopoietic cell	11
to platelet engraftment was	11
and platelet engraftment were	11
with an increase in	11
number of patients with	11
in cells infected with	11
matched related or unrelated	11
were significantly increased in	11
the risk of relapse	11
compared to those without	11
of reactive oxygen species	11
samples were collected from	11
in the central nervous	11
between and were included	11
stem cell transplant recipients	11
an important role for	11
patients who do not	11
mg m on days	11
the medical records of	11
may be an effective	11
of human monoclonal antibodies	11
investigated the role of	11
in order to evaluate	11
adverse events were reported	11
between january and november	11
the natural history of	11
of the most frequent	11
t cell proliferation and	11
similar to that of	11
aimed to determine the	11
in the patients with	11
as a marker for	11
in patients who underwent	11
in vivo and in	11
the pi k akt	11
who was diagnosed with	11
balb c mice were	11
critical role in the	11
free and overall survival	11
patients with haematological malignancies	11
in patients with primary	11
the patient and the	10
not been reported in	10
under the control of	10
specific t cells from	10
incidence of relapse was	10
all but one patient	10
was referred to immunology	10
here we report the	10
was similar in both	10
at our institution between	10
cellular and humoral immunity	10
the intensity of the	10
mobilized peripheral blood stem	10
the percentage of patients	10
in acute myeloid leukemia	10
patients who were treated	10
patients received a median	10
test was used for	10
the prognostic significance of	10
status of the patient	10
with regard to the	10
was performed in the	10
cd t cell counts	10
an autosomal recessive disorder	10
acute and chronic graft	10
hematopoietic stem cell transplants	10
was no difference between	10
in the generation of	10
of acute gvhd was	10
are known to be	10
of t cell receptor	10
of acute myeloid leukemia	10
within the normal range	10
to be able to	10
cases have been reported	10
were not statistically different	10
patients with a diagnosis	10
independent risk factor for	10
cd ra and cd	10
t cell activation and	10
was used to identify	10
the productive virus cycle	10
the patient presented with	10
an average age of	10
activation and proliferation of	10
bone marrow failure syndromes	10
was no statistical difference	10
overall survival rate was	10
were observed in the	10
has not been well	10
was considered statistically significant	10
was used to evaluate	10
and risk of multiple	10
we investigated the role	10
considered in patients with	10
there was no evidence	10
variants of unknown significance	10
for the prevention of	10
hematopoietic stem cell transplantations	10
for the identification of	10
this retrospective study was	10
and all of them	10
first reported case of	10
leading cause of death	10
the overall incidence of	10
with human immunodeficiency virus	10
whole exome sequencing revealed	10
by a variety of	10
as an alternative to	10
for the generation of	10
difference was not statistically	10
patients with chronic gvhd	10
regimens were used in	10
retrospective study was to	10
in the face of	10
a consequence of the	10
was detected in of	10
old male presented with	10
as well as an	10
day was associated with	10
for the entire cohort	10
bone marrow transplantation unit	10
study is to compare	10
graft failure was observed	10
and failure to thrive	10
stages of the disease	10
a significant difference in	10
in the form of	10
the decision was made	10
lost to follow up	10
is a rare but	10
no significant difference was	10
patients received bone marrow	10
the ages of and	10
we aimed to evaluate	10
knowledge this is the	10
over years of age	10
and the impact of	10
consent was obtained from	10
granulocyte colony stimulating factor	10
in patients with no	10
the t cell receptor	10
of patients with scd	10
were used to determine	10
of patients who had	10
the first days post	10
an independent prognostic factor	10
no differences in the	10
in the group with	10
the peripheral blood of	10
to determine whether the	10
the primary outcome was	10
the first reported case	10
in order to provide	10
old woman presented with	10
associated with higher risk	10
and the need for	10
a homozygous mutation in	10
compared to those who	10
mg kg day for	10
cumulative incidence of grade	10
and the majority of	10
the progression of the	10
the most commonly used	10
of the entire cohort	10
isolated from peripheral blood	10
to the hospital with	10
study is to investigate	10
in the immune response	10
patients developed acute gvhd	10
the mechanism of action	10
common variable immune deficiency	10
these data show that	10
our objective is to	10
these results indicate that	10
patients did not receive	10
of patients with acute	10
been previously reported in	10
associated with a poor	10
the cause of death	10
is essential for the	10
used in combination with	10
approved for the treatment	10
of b cells and	10
lower in patients with	10
is an effective treatment	10
has received honoraria from	10
analyses were performed using	10
has a history of	10
report the first case	10
compared to patients who	10
aim was to determine	10
gd t cells in	10
with a higher risk	10
the cumulative incidences of	10
that the presence of	10
with the expression of	10
as well as their	10
exome sequencing was performed	10
a significant impact on	10
our knowledge this is	10
as compared to patients	10
been associated with increased	10
in order to study	10
differences were observed in	10
has not yet been	10
time to neutrophil recovery	10
was identified in the	10
as a treatment option	10
patient was found to	10
was assessed by flow	10
group and the control	10
were used to assess	10
exome sequencing revealed a	10
evaluated by flow cytometry	10
was a trend towards	10
may serve as a	10
of patients with primary	10
to hematopoietic stem cell	10
reduce the incidence of	10
with relapsed or refractory	10
associated with a lower	10
might be due to	10
pediatric and young adult	10
to our hospital for	10
determine the prevalence of	10
for the induction of	10
was performed in a	10
we present our experience	10
is the most commonly	10
t cells and nk	10
significantly associated with the	10
patients with cmv reactivation	10
were transplanted in cr	10
appears to be an	10
evaluate the efficacy of	10
present a patient with	10
patients included in the	10
the pediatric intensive care	10
after the onset of	10
have been used for	10
the clinical features of	10
mutation in exon of	10
anaplastic large cell lymphoma	10
ptcy as gvhd prophylaxis	10
to be due to	10
reported in patients with	10
as a part of	10
treatment in patients with	10
can be considered as	10
cd t cells was	10
especially in patients with	10
plays a key role	10
is considered to be	10
follow up was months	10
and none of the	10
x cd cells kg	10
the treatment of patients	10
is a rare condition	10
in sickle cell disease	10
have shown that the	10
here we describe a	10
characteristics are summarized in	10
on the immune system	10
common in patients with	10
as the presence of	10
in of patients with	10
pediatric renal transplant recipients	10
chart review of all	10
the first time that	10
treatment option for patients	10
it remains to be	10
review of patients with	10
a larger number of	10
university school of medicine	10
in patients with sickle	10
results of this study	10
was bone marrow in	10
the main aim of	10
risk acute myeloid leukemia	10
of the expression of	10
analysis was performed by	10
within the first days	10
a bone marrow biopsy	10
the patients in the	10
included in the differential	10
order to study the	10
newborn screening for scid	10
in patients undergoing hsct	10
appears to be a	10
nothing to declare methods	10
in the early phase	10
an increased incidence of	10
also been associated with	10
significant differences were observed	10
we could show that	10
found to be significantly	10
high dose chemotherapy followed	10
from peripheral blood of	10
the early phase of	10
evaluate the effect of	10
were found in the	10
statistically significant difference in	9
the immune system in	9
is no consensus on	9
over the last years	9
of the productive cycle	9
there have been no	9
stem cell transplantation with	9
with higher risk of	9
cells were incubated with	9
over the age of	9
studies are warranted to	9
the mechanism by which	9
cd cd t cells	9
performed in our center	9
that is associated with	9
the genetic correlation between	9
significantly higher than that	9
to assess the impact	9
vg vd t cell	9
due to the high	9
increase the number of	9
of vg vd t	9
of moderate to severe	9
infused cd cell dose	9
significant differences in the	9
did not find any	9
cell carcinoma of the	9
of patients diagnosed with	9
were detected in the	9
the treatment of chronic	9
and bone marrow in	9
is more common in	9
t cell response to	9
cd ro memory t	9
are needed to determine	9
in the progression of	9
of acute graft versus	9
the surface of the	9
did not result in	9
severe t cell lymphopenia	9
was started at a	9
months after initiation of	9
from diagnosis to transplant	9
followed by autologous hematopoietic	9
cells were treated with	9
a rare cause of	9
have been found to	9
did not have a	9
at the level of	9
of the presence of	9
be due to the	9
the results of our	9
one of the patients	9
of a cohort of	9
vivo and in vitro	9
within the first hours	9
also found to have	9
regimen was myeloablative in	9
in the etiology of	9
the risk of multiple	9
the role of ebv	9
patients were transplanted from	9
in our study we	9
the percentage of th	9
has been used for	9
both in terms of	9
and melphalan mg m	9
the clinical manifestations of	9
has been found in	9
management of these patients	9
can be used for	9
gene expression in the	9
of unknown significance in	9
this study shows that	9
platelet engraftment was days	9
has emerged as a	9
at a young age	9
associated with multiple sclerosis	9
and risk factors for	9
in the first years	9
found in patients with	9
should be included in	9
cells in peripheral blood	9
of donor t cells	9
a low incidence of	9
at time of transplant	9
the expression of these	9
the diagnosis of a	9
was observed in a	9
our center between and	9
the cd t cells	9
clinical and laboratory features	9
transplant related mortality was	9
aim was to assess	9
compared with control group	9
based on the presence	9
we have investigated the	9
increase in the number	9
at our center between	9
innate and adaptive immunity	9
syndrome is a rare	9
cell source was bone	9
statistically significant differences in	9
the study of the	9
and chronic gvhd in	9
w i t h	9
described in patients with	9
all patients were alive	9
the end of treatment	9
enrolled in this study	9
is caused by a	9
a significant decrease of	9
case report of a	9
patients with acute gvhd	9
of peripheral blood stem	9
to the fact that	9
did not affect the	9
remains to be determined	9
risk factors for the	9
here we report our	9
the risk of graft	9
our study shows that	9
is a rare form	9
source was pb in	9
no significant differences between	9
characteristics are shown in	9
patients older than years	9
a standard of care	9
should be monitored closely	9
pediatric patients with scd	9
as soon as possible	9
blood was used as	9
of systemic lupus erythematosus	9
of the role of	9
in patients who developed	9
the first years of	9
are alive and well	9
safe and effective in	9
serum levels of il	9
analysis was performed with	9
the length of appendix	9
due to differences in	9
in the cytoplasm of	9
during the period of	9
positive plasma cells and	9
and chronic gvhd were	9
a wide variety of	9
to evaluate the incidence	9
of stem cells was	9
was used for the	9
conditioning regimen followed by	9
study is needed to	9
emphasize the importance of	9
were determined by flow	9
is a rare and	9
bone marrow transplantation in	9
of mhc class i	9
of inflammatory bowel disease	9
the efficacy of the	9
significant differences were found	9
describe a patient with	9
has also been associated	9
study was approved by	9
the main objective of	9
vgamma vdelta t cells	9
in the percentage of	9
patients with mixed chimerism	9
a small number of	9
t cells with a	9
be associated with the	9
and negative for cd	9
inherited bone marrow failure	9
this cohort of patients	9
play a crucial role	9
recipients of allogeneic hematopoietic	9
up time was months	9
cohort of pediatric patients	9
a higher percentage of	9
be used as an	9
t cells and the	9
due to graft failure	9
a decrease in the	9
infections as well as	9
the authors declare no	9
cd cells per kg	9
failure to thrive and	9
was carried out by	9
most frequent cause of	9
cells in patients with	9
important risk factor for	9
the early stages of	9
after the end of	9
significantly higher than those	9
performed according to the	9
before start of conditioning	9
in the posttransplant period	9
deficiency is a rare	9
specific t cell responses	9
a significant number of	9
been found to be	9
been associated with a	9
and of the patients	9
a significant risk factor	9
in patients with ebv	9
the expression levels of	9
associated with an increase	9
the production of il	9
in children treated with	9
dna was extracted from	9
in a significant proportion	9
in patients with low	9
associated with a significantly	9
the lower limit of	9
society for blood and	9
was identified as a	9
g for min at	9
it is believed that	9
there were no statistically	9
of cd cells on	9
is shown in table	9
associated with a significant	9
are associated with the	9
by western blot analysis	9
of memory b cells	9
and revised the manuscript	9
analysis was performed on	9
aim was to evaluate	9
we aimed to investigate	9
objective of the study	9
the polymerase chain reaction	9
was associated with the	9
did not have any	9
treatment of choice for	9
in the period from	9
the use of ebv	9
one of the following	9
cells in the peripheral	9
were used to evaluate	9
the use of plerixafor	9
unrelated umbilical cord blood	9
of patients was years	9
transplantation for patients with	9
was used to measure	9
to the activation of	9
have been found in	9
it has not been	9
was not detected in	9
in up to of	9
in patients with relapsed	9
of children and adolescents	9
samples were obtained from	9
old woman with a	9
majority of patients with	9
was significantly reduced in	9
cells in the graft	9
an increased frequency of	9
donor was unrelated in	9
of nk cells in	9
probably due to the	9
study included patients with	9
with a high risk	9
confirmed by sanger sequencing	9
in patients with ms	9
as well as other	9
in the transplant recipient	9
received myeloablative conditioning regimen	9
large cohort of patients	9
the expression of il	9
which may lead to	9
no differences were observed	9
cd cells on day	9
the beginning of the	9
to the type of	9
the results suggest that	9
occurred in of patients	9
main aim of this	9
in this group of	9
at the day of	9
was significantly lower than	9
here we present the	9
of t cells and	9
in recipients of allogeneic	9
was the main cause	9
in a pediatric patient	9
is a rare complication	9
was more common in	9
at a median age	9
primary immunodeficiency characterized by	9
by the expression of	9
received a median of	9
two patients had a	9
median dose of cd	9
as one of the	9
incidence and risk factors	9
she did not have	9
patients were followed for	9
in at least one	9
acute gvhd occurred in	9
is a rare primary	9
was used to assess	9
a negative regulator of	9
is a rare benign	9
should be taken into	9
to the intensive care	9
at time of diagnosis	9
of the patients are	9
significant risk factor for	9
a total of pts	9
in patients with hematological	9
the innate immune response	9
of the patients developed	9
was used to determine	9
haploidentical bone marrow transplantation	9
increased risk of developing	9
cd t cells by	9
with a mean of	9
of this study are	9
majority of patients had	9
centers for disease control	9
did not influence the	9
blood stem cells were	9
received a myeloablative conditioning	9
of acute lymphoblastic leukemia	9
small cell lung cancer	9
incidence of cmv infection	9
cd cd cd ra	9
difference was not significant	9
a year old man	9
higher in patients who	9
overall survival at years	9
patients were followed up	9
after a median time	9
is a major complication	9
statistically significant association between	9
of red blood cells	9
to the pathogenesis of	9
female with a history	9
authors have nothing to	9
in the mel group	9
play a major role	9
contribute to the development	9
was associated with higher	9
variant of uncertain significance	9
patient died due to	9
the median interval from	9
there is a high	9
european society for blood	8
was the only factor	8
levels were significantly higher	8
at months after hsct	8
the national institute of	8
were males and females	8
both innate and adaptive	8
was used to calculate	8
none of these patients	8
for pediatric patients with	8
dose chemotherapy and autologous	8
with at least one	8
one patient died of	8
is a rare event	8
of the first year	8
a case report of	8
for the production of	8
to the number of	8
of stem cells in	8
as graft versus host	8
has been demonstrated in	8
assess the impact of	8
investigated the impact of	8
conditioning regimen consisting of	8
who did not have	8
has been proven to	8
peripheral blood was used	8
are often associated with	8
is due to the	8
the causes of death	8
remains one of the	8
in order to assess	8
acute myeloid leukemia patients	8
the head and neck	8
to cd t cells	8
the conditioning regimen for	8
to those who did	8
in a univariate analysis	8
free survival and overall	8
acute gvhd grade i	8
increased susceptibility to infection	8
the sensitivity and specificity	8
with the risk of	8
differences were found in	8
of patients with multiple	8
disease status at the	8
does not appear to	8
we report here the	8
mg kg on days	8
chimeric antigen receptor t	8
improve the outcome of	8
were excluded due to	8
patients at a median	8
had a diagnosis of	8
retrospective analysis of patients	8
levels were measured by	8
the incidence of gvhd	8
its role in the	8
associated hemophagocytic syndrome in	8
failure was observed in	8
in the serum of	8
in order to improve	8
there was no correlation	8
was no evidence of	8
important to note that	8
shown to be a	8
is believed to be	8
the identification of a	8
conflicts of interest to	8
is a retrospective study	8
patients with history of	8
in patients with lymphoma	8
affecting cellular and humoral	8
in peripheral blood of	8
there was also a	8
should be aware of	8
received a reduced intensity	8
started at a median	8
viral and bacterial infections	8
this retrospective study we	8
for allogeneic stem cell	8
t cells have been	8
patients were male and	8
in cd and cd	8
and disease status at	8
vascular endothelial growth factor	8
to reduce the risk	8
was lost to follow	8
performed a retrospective study	8
of renal tubular epithelial	8
in the department of	8
the study was conducted	8
were more common in	8
we conclude that the	8
extensive chronic gvhd was	8
it is characterized by	8
patients were started on	8
months in patients who	8
the use of g	8
specific t cells were	8
the most common causes	8
of the skin and	8
in tonsils and adenoids	8
was more frequent in	8
between these two groups	8
from months to years	8
the detection of ebv	8
to determine if the	8
the aim was to	8
reduced intensity conditioning regimens	8
two years of age	8
with bone marrow failure	8
can be difficult to	8
needed in order to	8
the level of the	8
did not differ significantly	8
blood and marrow transplant	8
class i and ii	8
not been previously described	8
an increased susceptibility to	8
had no impact on	8
do not seem to	8
moderate to severe chronic	8
barr virus latent membrane	8
is dependent on the	8
efficacy and toxicity of	8
were used in the	8
that can be used	8
the effect of the	8
role in the regulation	8
of the united states	8
supported in part by	8
at diagnosis was years	8
a small cohort of	8
survival at years was	8
we have found that	8
of clinical and laboratory	8
hsct in children with	8
could serve as a	8
did not receive ivig	8
in univariate and multivariate	8
pediatric hematology oncology fellowship	8
a prospective observational study	8
specific cytotoxic t cells	8
of recurrent infections and	8
patient was admitted to	8
is to assess the	8
for patients with severe	8
probability of overall survival	8
at the national institutes	8
the importance of the	8
all patients who received	8
during the prrs outbreak	8
acute gvhd of the	8
was calculated using the	8
kg day for days	8
the development of new	8
s p ratio with	8
patients who had a	8
with congenital heart disease	8
can be used in	8
the management of these	8
prognosis of patients with	8
were in partial remission	8
have been linked to	8
human gd t cells	8
of central nervous system	8
of squamous cell carcinoma	8
a variant of uncertain	8
cells from healthy donors	8
a prospective study of	8
mammalian target of rapamycin	8
was a significant difference	8
that can lead to	8
whole exome sequencing and	8
national institute of health	8
cd t cell count	8
a novel mutation in	8
to the risk of	8
there is limited data	8
before and after hsct	8
to a variety of	8
a median age at	8
an independent predictor of	8
the increased risk of	8
are at risk of	8
ecp procedures were performed	8
the function of the	8
in the last decade	8
in order to investigate	8
a history of severe	8
in balb c mice	8
will be needed to	8
transducer and activator of	8
compared to those of	8
showed an increase in	8
there is an urgent	8
showed a trend towards	8
and activator of transcription	8
with the number of	8
pi k akt mtor	8
braf v e mutation	8
in patients with mm	8
underwent hematopoietic stem cell	8
of the disease is	8
the expression of p	8
to severe chronic gvhd	8
and can lead to	8
a lower risk of	8
bacterial and fungal infections	8
for hematopoietic cell transplantation	8
study is to assess	8
age at onset of	8
of the patients included	8
play a critical role	8
the first months of	8
determine the role of	8
patients with a history	8
had a matched related	8
could be related to	8
moderate to severe cgvhd	8
prior to transplant and	8
has not been described	8
mg kg day and	8
incidence and prevalence of	8
immunodeficiencies affecting cellular and	8
no statistically significant association	8
the last two decades	8
to months after transplantation	8
signal transducer and activator	8
the first months after	8
the most common form	8
parts of the world	8
with the ability to	8
in paediatric patients with	8
the median overall survival	8
cd cd double positive	8
of acute kidney injury	8
the treatment of ebv	8
from the bone marrow	8
could be used as	8
in a multivariate analysis	8
the causative agent of	8
which can lead to	8
might be involved in	8
diagnosis is based on	8
during the first months	8
our results showed that	8
significant increase in the	8
patients who received hsct	8
year os and pfs	8
of extensive chronic gvhd	8
was significantly better in	8
to our knowledge this	8
patients met inclusion criteria	8
than that in the	8
of the patient and	8
risk of cmv reactivation	8
haematopoietic stem cell transplant	8
the host immune response	8
patients with common variable	8
in response to the	8
patients who received allo	8
in one of the	8
in terms of os	8
the management of patients	8
that they have no	8
to assess the efficacy	8
as the use of	8
and did not receive	8
but not in the	8
at the dose of	8
the remaining patients were	8
lymphocyte proliferation to mitogens	8
may be considered as	8
the risk of infection	8
may be used to	8
are listed in table	8
leading cause of morbidity	8
should be performed in	8
were randomly divided into	8
were no statistically significant	8
as part of a	8
has not been established	8
significant cause of morbidity	8
of cmv reactivation in	8
between and years of	8
both acute and chronic	8
who initially presented with	8
neonatal intensive care unit	8
in patients with hematologic	8
of at least one	8
were not associated with	8
that may contribute to	8
in human immunodeficiency virus	8
shown to be effective	8
the basis of the	8
undergoing hematopoietic stem cell	8
for cd and cd	8
overall response rate was	8
conditioning regimens were used	8
in the study of	8
bone marrow and peripheral	8
memory b cells and	8
have been treated with	8
nk cells in the	8
patients who underwent haplo	8
we have identified a	8
who underwent allogeneic hsct	8
from the peripheral blood	8
cumulative incidence of agvhd	8
high levels of the	8
has not been studied	8
time to nd allo	8
the first dose of	8
were used to compare	8
have a role in	8
were positive for cd	8
cells from patients with	8
the patient was discharged	8
the use of high	8
excluded from the analysis	8
a larger cohort of	8
with severe aplastic anemia	8
the context of a	8
the clinical significance of	8
of t cells with	8
has been previously reported	8
and was treated with	8
were identified in the	8
which was consistent with	8
of children with cancer	8
to evaluate the effect	8
were used to analyze	8
in adults and children	8
needed to confirm these	8
the specificity of the	8
of s p ratio	8
of the impact of	8
all of them received	8
was associated with increased	8
a rare complication of	8
patients were alive and	8
was detected in the	8
is possible that the	8
the presence of an	8
neonatal vg vd t	8
renal tubular epithelial cell	8
key role in the	8
is associated with poor	8
to be higher in	8
significantly lower in patients	8
to be aware of	8
statistically significant difference between	8
igg positive plasma cells	8
more studies are needed	8
atypical hemolytic uremic syndrome	8
from a matched sibling	8
graft vs host disease	8
a broad range of	8
the study group was	8
is not fully understood	8
be taken into consideration	8
t cells from the	8
did not correlate with	8
absolute counts of cd	8
age at diagnosis of	8
of one or more	8
this is a prospective	8
marrow and peripheral blood	8
in pediatric oncology patients	8
could be due to	8
the objective of the	8
not differ between the	8
divided into three groups	8
and a history of	8
cells was observed in	8
at risk of developing	8
patients with bone marrow	8
adult and pediatric patients	8
found to be associated	8
after days of treatment	8
were found in patients	8
infection is associated with	8
with high morbidity and	8
recurrent upper respiratory tract	8
stem cell sources were	8
has an important role	8
and secondary graft failure	8
at our center from	8
analysis was performed to	8
with primary immune deficiency	8
of infection in the	8
report our experience of	8
might be associated with	8
from peripheral blood mononuclear	8
the first time in	8
mechanisms involved in the	8
of the patients and	8
were performed according to	8
barr virus and multiple	8
although the number of	8
and the role of	8
was achieved in of	8
the possible role of	8
the most common indication	8
in patients diagnosed with	8
a high number of	8
has been linked to	8
progression of the disease	8
in a larger cohort	8
has been used in	8
all patients except one	8
after weeks of treatment	8
index of suspicion for	8
there is a significant	8
had been diagnosed with	8
under the age of	8
used in patients with	8
were no differences between	8
are presented in table	8
patients developed chronic gvhd	8
and may lead to	8
received stem cells from	8
the small number of	8
survival and overall survival	8
were compared to those	8
and adaptive immune responses	8
virus and multiple sclerosis	8
total of cases of	8
division of intramural research	8
for graft versus host	8
group of patients who	8
included in this analysis	8
a phase i ii	8
from matched unrelated donor	8
an important cause of	8
median time for neutrophil	8
our goal was to	8
iv acute gvhd and	8
of nkg d ligands	8
under years of age	8
expression of cd in	8
of the genetic correlation	8
as compared to those	8
it is not known	8
we have previously reported	8
for the majority of	8
we can conclude that	8
for at least months	8
be taken into account	8
our cohort of patients	8
of total body irradiation	8
in multiple myeloma patients	8
we report a patient	8
order to determine the	8
compared with the control	8
highly active antiretroviral therapy	8
have the ability to	8
not statistically different between	8
patient is a year	8
in the beam group	8
by polymerase chain reaction	8